Mar 30, 2026 07:19AM
Feb 18, 2026 07:19AM
Feb 18, 2026 07:19AM
Feb 12, 2026 06:15PM
Dec 18, 2025 07:31AM
Dec 18, 2025 07:31AM
Nov 13, 2025 05:21PM Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2026
Nov 5, 2025 07:16AM
Nov 5, 2025 07:16AM
Oct 22, 2025 07:20AM
Oct 1, 2025 07:17AM
Oct 1, 2025 07:17AM
Sep 23, 2025 05:02PM
Sep 23, 2025 05:01PM Appili Therapeutics Announces Results of Annual and Special Meeting of Shareholders
Sep 9, 2025 07:20AM
Aug 14, 2025 05:05PM
Jun 25, 2025 06:04PM
Apr 28, 2025 07:41AM
Apr 2, 2025 08:17AM
Mar 18, 2025 07:22AM
Feb 14, 2025 05:06PM Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2025
Nov 14, 2024 07:15AM
Nov 7, 2024 08:30AM
Nov 6, 2024 08:30AM
Oct 31, 2024 08:30AM
Oct 28, 2024 08:15AM
Oct 17, 2024 07:15AM
Oct 10, 2024 08:15AM Aditxt’s Acquisition Target Appili Therapeutics Will Hold a Special Meeting of Shareholders on November 6, 2024, to Vote on the Transaction and Secure Appili’s Shareholder Approval
Oct 10, 2024 07:13AM
Oct 3, 2024 08:15AM
Sep 17, 2024 05:11PM
Aug 13, 2024 05:19PM
Jul 25, 2024 08:30AM
Jun 25, 2024 05:46PM
Apr 2, 2024 08:30AM Aditxt, Inc (ADTX) to Acquire Appili Therapeutics
Apr 2, 2024 08:30AM
Mar 12, 2024 07:12AM
Dec 15, 2023 07:27AM
Nov 13, 2023 04:24PM
Oct 25, 2023 07:49AM
Sep 27, 2023 07:21PM
Sep 25, 2023 07:54AM Appili Therapeutics Announces U.S. FDA Approval of LIKMEZ™ (ATI-1501) Metronidazole Oral Suspension
Aug 11, 2023 04:50PM
Jun 23, 2023 05:07PM
Jun 23, 2023 07:21AM
May 24, 2023 07:19AM
May 8, 2023 07:38AM
Apr 18, 2023 07:17AM
Apr 3, 2023 07:22AM Appili Therapeutics Appoints Dr. Gary Nabors as Chief Development Officer
Feb 14, 2023 07:18AM

322,212 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All